The tablet formulation of zanubrutinib (Brukinsa; BeOne) is now approved for all 5 indications across several hematological ...

Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

Genentech, a member of the Roche Group, has announced that it is voluntarily withdrawing the US indication of Tecentriq (atezolizumab) for the treatment of adult patients with certain types of ...

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...

Renal failure in multiple myeloma typically occurs when the kidneys fail to filter waste products from the blood, leading to ...

It's the seventh approved indication for the IL4 and IL13-inhibiting monoclonal antibody, which is already a blockbuster for Sanofi. CSU has also not had a new treatment approved in more than a ...

Various antibiotic classes, including β-lactams, carbapenems, fluoroquinolones, aminoglycosides, tetracyclines, and macrolides, can be broken down or altered by a broad range of resistance enzymes ...

We're All Ears for Celebrity Buzz! Please enter a name. Please enter a valid email. Please enter a phone number. Please enter a message. Send the Tip! Us Weekly has affiliate partnerships so we ...